PARKINSON'S ACTION NETWORK for PARKINSON'S ACTION NETWORK
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Jul 11, 2016 | $50,765 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 20, 2017 | $50,765 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Environment/Superfund ENV
"S.697, Frank R. Lautenberg Chemical Safety for the 21st Century Act," all sections.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES TUCKER | — |
Family issues/Abortion/Adoption FAM
"H.R. 263, Adult Day Center Enhancement Act," all sections; and "S. 1549, The Care Planning Act of 2015," all sections.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER SHERIDAN PALUTE | — |
Medicare/Medicaid MMM
"H.R. 775/S. 539, Medicare Access to Rehabilitation Services Act," all sections;"H.R. 3081/S.1778, The TELE-Med Act, all sections;"H.R. 2624/S. 1488, The Part D Beneficiary Fairness Appeals Act," all sections; "The Veterans E-Health and Telemedicine Support Act," (S. 2170); Medicare support for FDA breakthrough therapies (coalition sign-on support letter)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES TUCKER | — |
Medical/Disease Research/Clinical Labs MED
"The Senate Innovations Initiative," issues related to funding for NIH and FDA, data collection, therapeutic incentives, patient engagement, telehealth, and clinical trials; "H.R. 292/S. 849, The Advancing Research for Neurological Diseases Act," all sections;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES TUCKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.